benefit
(statisticaly significant)
benefit (nominaly significant, not statitically demonstrated) NS not significant harm statitically significant NS harm not significant low certainty due to bias
 
iDFS

breast cancer - adjuvant breast cancer - adjuvant

versus placebo
everolimus vs. placebo 1 -